Russell Investments Group’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
Russell Investments Group's OPRX Position: Q2 2026 in Review
Russell Investments Group reduced its OptimizeRx (OPRX) stake by 99% in Q2 2026, selling an estimated $716K and leaving 885 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4035.
Russell Investments Group first reported a position in OPRX in Q3 2018 and has held it in 28 quarters since. The position peaked at $7.09M in Q3 2021. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.
- Russell Investments Group held 885 shares of OptimizeRx worth $5.06K as of Q2 2026.
- Russell Investments Group sold 124,608 OptimizeRx shares in Q2 2026, an estimated $716K.
- OptimizeRx made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #4035 holding.
- Russell Investments Group first reported a position in OptimizeRx in Q3 2018 and has held it in 28 quarters since.
- Russell Investments Group's OptimizeRx position peaked at $7.09M in Q3 2021.
- 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.